The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lewy Body Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lewy Body Disease


Psychiatry related information on Lewy Body Disease


High impact information on Lewy Body Disease


Chemical compound and disease context of Lewy Body Disease


Anatomical context of Lewy Body Disease


Gene context of Lewy Body Disease


Analytical, diagnostic and therapeutic context of Lewy Body Disease


  1. alpha-Synuclein affects the MAPK pathway and accelerates cell death. Iwata, A., Maruyama, M., Kanazawa, I., Nukina, N. J. Biol. Chem. (2001) [Pubmed]
  2. Fas antigen expression in brains of patients with Alzheimer-type dementia. Nishimura, T., Akiyama, H., Yonehara, S., Kondo, H., Ikeda, K., Kato, M., Iseki, E., Kosaka, K. Brain Res. (1995) [Pubmed]
  3. Increase of adenomatous polyposis coli immunoreactivity is a marker of reactive astrocytes in Alzheimer's disease and in other pathological conditions. Leroy, K., Duyckaerts, C., Bovekamp, L., Müller, O., Anderton, B.H., Brion, J.P. Acta Neuropathol. (2001) [Pubmed]
  4. Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease. Arai, T., Akiyama, H., Ikeda, K., Kondo, H., Mori, H. Brain Res. (1999) [Pubmed]
  5. The role of protein ubiquitination in neurodegenerative disease. Mayer, R.J., Lowe, J., Landon, M., McDermott, H., László, L. Acta. Biol. Hung. (1991) [Pubmed]
  6. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Takeda, A., Mallory, M., Sundsmo, M., Honer, W., Hansen, L., Masliah, E. Am. J. Pathol. (1998) [Pubmed]
  7. Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease. Ohara, K., Kondo, N., Ohara, K. Prog. Neuropsychopharmacol. Biol. Psychiatry (1998) [Pubmed]
  8. Differential diagnosis in dementia. Cras, P. Acta neurologica Belgica. (1998) [Pubmed]
  9. Update on rivastigmine. Farlow, M.R. The neurologist. (2003) [Pubmed]
  10. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Litvan, I., Campbell, G., Mangone, C.A., Verny, M., McKee, A., Chaudhuri, K.R., Jellinger, K., Pearce, R.K., D'Olhaberriague, L. Brain (1997) [Pubmed]
  11. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Iwatsubo, T., Yamaguchi, H., Fujimuro, M., Yokosawa, H., Ihara, Y., Trojanowski, J.Q., Lee, V.M. Am. J. Pathol. (1996) [Pubmed]
  12. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Brion, J.P., Couck, A.M. Am. J. Pathol. (1995) [Pubmed]
  13. Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Turner, R.S., Chervin, R.D., Frey, K.A., Minoshima, S., Kuhl, D.E. Neurology (1997) [Pubmed]
  14. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Galasko, D., Saitoh, T., Xia, Y., Thal, L.J., Katzman, R., Hill, L.R., Hansen, L. Neurology (1994) [Pubmed]
  15. The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Mann, D.M., Snowden, J.S. Acta Neuropathol. (1995) [Pubmed]
  16. Autonomic dysfunction in Parkinson's disease. Koike, Y., Takahashi, A. Eur. Neurol. (1997) [Pubmed]
  17. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Chung, K.K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J.C., Marsh, L., Dawson, V.L., Dawson, T.M. Science (2004) [Pubmed]
  18. Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. McLean, P.J., Kawamata, H., Ribich, S., Hyman, B.T. J. Biol. Chem. (2000) [Pubmed]
  19. Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Dalfó, E., Barrachina, M., Rosa, J.L., Ambrosio, S., Ferrer, I. Neurobiol. Dis. (2004) [Pubmed]
  20. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Dickson, D.W., Schmidt, M.L., Lee, V.M., Zhao, M.L., Yen, S.H., Trojanowski, J.Q. Acta Neuropathol. (1994) [Pubmed]
  21. Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains. Kwak, S., Masaki, T., Ishiura, S., Sugita, H. Neurosci. Lett. (1991) [Pubmed]
  22. Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein. Arai, T., Uéda, K., Ikeda, K., Akiyama, H., Haga, C., Kondo, H., Kuroki, N., Niizato, K., Iritani, S., Tsuchiya, K. Neurosci. Lett. (1999) [Pubmed]
  23. Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. Kawanishi, C., Suzuki, K., Odawara, T., Iseki, E., Onishi, H., Miyakawa, T., Yamada, Y., Kosaka, K., Kondo, N., Yamamoto, T. J. Neurol. Sci. (1996) [Pubmed]
  24. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Johnson, J., Hague, S.M., Hanson, M., Gibson, A., Wilson, K.E., Evans, E.W., Singleton, A.A., McInerney-Leo, A., Nussbaum, R.L., Hernandez, D.G., Gallardo, M., McKeith, I.G., Burn, D.J., Ryu, M., Hellstrom, O., Ravina, B., Eerola, J., Perry, R.H., Jaros, E., Tienari, P., Weiser, R., Gwinn-Hardy, K., Morris, C.M., Hardy, J., Singleton, A.B. Neurology (2004) [Pubmed]
  25. Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease. Takahashi, M., Iseki, E., Kosaka, K. Brain Res. (2000) [Pubmed]
  26. Amyloid angiopathy in diffuse Lewy body disease. Wu, E., Lipton, R.B., Dickson, D.W. Neurology (1992) [Pubmed]
  27. Neuronal expression of class II major histocompatibility complex (HLA-DR) in 2 cases of Pick disease. Hollister, R.D., Xia, M., McNamara, M.J., Hyman, B.T. Arch. Neurol. (1997) [Pubmed]
  28. Odor identification deficits in diffuse lewy body disease. Westervelt, H.J., Stern, R.A., Tremont, G. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology. (2003) [Pubmed]
WikiGenes - Universities